Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LFST · against 233 other Healthcare companies of similar size
Ranked #147 of 234 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score27 peers with a valuation score of 40–49, including LFST · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | LFST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 232 reported | 1.0% | 2.4% | 38% | 30% | |
| EBITDA yieldHigher is better · 231 reported | 2.5% | 4.5% | 37% | 50% | |
| Free cash flow yieldHigher is better · 127 reported | 3.4% | 0.9% | 70% | 20% | |
| Book yieldHigher is better · 233 reported | 28.9% | 25.7% | 55% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 141 | 5.7B USD | 44 | 38 | |
| 141 | 5.9B USD | 44 | 39 | |
| 145 | 40.3B SEK (≈$4.0B) | 43 | 79 | |
| 145 | 4.6B USD | 43 | 65 | |
| 147 | 5.1B USD | 42 | 52 | |
| 147 | 2.7B USD | 42 | 56 | |
| 147 | 5.8B USD | 42 | 38 | |
| 147 | 303.5B INR (≈$3.6B) | 42 | 47 | |
| 151 | 64.1B CNY (≈$9.0B) | 41 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score